1University of Parma, Parma, Italy [email protected]
2United Lincolnshire Hospitals NHS Trust, Lincoln, United Kingdom
Dr. Bersanelli reports receiving research funds from Roche, Pfizer, Seqirus, AstraZeneca, Bristol-Myers Squibb, Novartis, and Sanofi and consulting and speaking fees from Bristol-Myers Squibb, Novartis, and Pfizer; Dr. Tiseo, receiving consulting and speaking fees from AstraZeneca, Pfizer, Eli Lilly, Bristol-Myers Squibb, Novartis, Roche, MSD, Boehringer Ingelheim, Otsuka, Takeda, and Pierre Fabre and research grants from AstraZeneca and Boehringer Ingelheim; and Dr. Banna, receiving consulting and speaking fees from Janssen-Cilag, Boehringer Ingelheim, Roche, MSD, and AstraZeneca. No other potential conflict of interest relevant to this letter was reported.
